Does anyone know what the future holds for the Eagan and Ann Arbor office locations?
Are these locations being deprioritized? Any plans to close either or both?
9 replies (most recent on top)
@dt If that. I have gone in all different days and it is empty. Wasting money to power an empty building so to save money you lay off hardworking loyal people and completely disrupt their lives, all so you can keep paying for those empty desks to sit there.
TR owns the Ann Arbor building. Commercial real estate seems sleepy in Ann Arbor and it’s a weird location. It’s quite far from the university too, so I’d be surprised if they bought it. No other companies have a wide enough foot print these days. Curious to see what happens, but I know I don’t want to drive somewhere like Livonia or something if TR does sell this building.
@2en I was talking about the Ann Arbor office. The other poster mentioned Prime Therapeutics, not me. In any case, I am not clear why Ann Arbor is continuing to maintain this giant building that is 3/4 empty, whether it's owned or leased. I think it is a fair question.
@29h The Eagan office is leased from Prime Therapeutics. It sounds like you are confusing this with the Ann Arbor office.
@28w "They are leasing it from Prime Therapeutics."
Why, though? The lease was up at the end of 2024. After they let go so many Ann Arbor staff, why renew the lease? It's not like they are hiring anybody in Ann Arbor.
@ec the didn’t buy it. They are leasing it from Prime Therapeutics.
They want to move jobs to lower cost locations so I expect those locations to shrink.
Why did Thomson Reuters buy the building? Wasn't it originally a lease when the former tenant moved out?
No word yet. But it seems crazy we have a building that can hold 1200+ people and like 100 show up a week in AA.